New York, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The global cancer cachexia market size is predicted to grow at a CAGR of over 4.5% from 2024 to 2036. The market is projected to garner a revenue of USD 4.5 ...

Recognizing the urgent need for treatment options and guided by patient insights, Pfizer scientists have discovered a way to ...

DelveInsight's Cancer Cachexia Market Insights report includes a comprehensive understanding of current treatment practices, cancer cachexia emerging drugs, market share of individual therapies, and ...

Pfizer researchers say they are developing a drug that might counteract a condition that leads to the death of cancer patients within a year of its diagnosis. Photo by Stephanie Lecocq/EPA-EFE Sept.

Cachexia – the massive depletion of muscle mass and adipose tissue – is commonly seen in people with cancer and other major illnesses. Also called cancer cachexia or cancer anorexia cachexia, it is a ...

Cachexia, defined as a loss of body weight, fat, and muscle mass that occurs in patients with chronic diseases, including cancer, remains a notable clinical challenge. With limited viable treatment ...

Cancer often results in weight loss due to unwanted metabolic complications. This so-called cancer cachexia is accompanied by a poor prognosis with regard to disease progression, quality of life, and ...

When tumours in cancer patients elevate levels of an immune system molecule called Interleukin-6 (IL-6), it can cause severe brain dysfunction, which leads to a lethal wasting disease called 'cachexia ...

Oncotarget recently published "Evaluation of cancer-derived myocardial impairments using a mouse model" which reported that Myocardial damage in cancer patients is emphasized as a cause of death; ...

Bonnie Addario didn’t even know there was a word for what was happening to her. As if lung cancer weren’t bad enough, the 54-year-old had lost 30 pounds off her normally 130-pound frame. Her life was ...